期刊文献+

MMP-9和COX-2在肾癌组织中的表达水平及临床意义 被引量:1

The significance and expression level of COX-2 and MMP-9 in renal cell carcinomar tissue
下载PDF
导出
摘要 目的探讨肾癌患者肿瘤组织中基质金属蛋白酶9(MMP-9)及环氧合酶2(COX-2)的表达水平及其临床意义。方法收集50例肾癌患者术后癌组织及20例肾良性病变手术后的肾组织(均经术后病理及影像学等检查确定),并按相应步骤进行切片,分别采用免疫组织化学PV6000两步法测定肾肿瘤组织中两种肿瘤标记物的表达水平,并进行统计学分析。结果肾癌患者肿瘤组织中的MMP-9及COX-2水平均较良性对照组染色明显(P【0.05)。其中肾癌组MMP-9的阳性率为86%,而COX-2在肾癌组中的阳性率为82%,二者表达水平明显呈正相关(r=0.039,P【0.05)。结论肾癌组织中MMP-9及COX-2都存在着过度表达,且二者均随肿瘤病理分级的增高而表达进一步强烈,证明二者在肾癌的发生、发展。 Objective To evaluate the expression and significance of cyclooxygenase-2(COX-2) and matrixmetallo-proteinase-9(MMP-9) in renal cancer.Methods The renal tumor tissues of 50 renal tumor patients and 20 patients with renal benign pathological changes were collected(confirmed by pathology and image).The tissue was made to a section,and then immunohistochemical PV6000 was performed to determine the expression level of two tumor markers,and statistical analysis was performed.Results The expression level of MMP-9 and COX-2 in renal tumor tissue is significant difference than in benign pathological changes(P<0.05).The postive rate of MMP-9 in renal tumor group was 82%,and the rate of COX-2 was 82%.There is positive correlaton between them(r=0.039,P<0.05).Conclusion There is excessive expression of MMP-9 and COX-2 in renal tumor tissue.There is further expression with the staging increasing.It prove that the two markers play an important role in occurance,development,infitation and transfer of renal cancer.
出处 《中国保健营养(下半月)》 2012年第5期1239-1240,共2页 China Health Care & Nutrition
关键词 肾癌 基质金属蛋白酶9 环氧合酶2 Renal cancer Matrixmetallo-proteinase-9 Cyclooxygenase-2
  • 相关文献

参考文献8

二级参考文献15

  • 1周洪澜,王医术,侯毅,李一雷,王心蕊,傅耀文.基质金属蛋白酶9在膀胱移行细胞癌中的表达及其意义[J].吉林大学学报(医学版),2005,31(2):309-310. 被引量:1
  • 2Hsieh JT, Dinney CP, Chung LW. The potential role of gene therapy in the treatment of bladder cancer. Uro Clin N Am, 2000,27(1): 103-113.
  • 3Taftachi R, Ayhan A, Ekici S, et al. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67. BJU Int, 2005,95(4):650-654.
  • 4Bozlu M, Orhan D, Baltaci S, et al. The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder. Int Urol Nephrol, 2002,33(1):59-66.
  • 5Hiroaki S, Mikio L, Haruhiko N, et al. Immunochistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of bladder.Caneer, 1996,78 (8): 1762-1766.
  • 6Morgan H, Hill PA. Human breast cancer cell-mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activity. Cancer Cell Int, 2005,5(1): 1-5.
  • 7Ozdemir E, Kakehi Y, Okuno H, et al.Role of matrix metalloproteinase-9 in the basement membrance destruction of superficial urothelial carcinoma. J Urol,1999,161(4):1359-1363.
  • 8Harrison OJ, Corps EM, Berge T, et al. The mechanism of cell adhesion by classical cadherins: the role of domain 1. J Cell Sci,2005, 118(Pt 4):711-721.
  • 9Nabeshima K, Inoue T, Shimao Y,et al.Cohort migration of carcinoma cells:differentiated colorectal carcinoma cells move as coherent cell clusters or sheets. Histol Histopathol, 1999,14(4): 1183 - 1187.
  • 10Imao T, Koshida K, Endo Y, et al. Namiki M. Dominant role of Ecadherin in the progression of bladder cancer. J Urol, 1999, 161(2):692-698.

共引文献14

同被引文献6

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部